Literature DB >> 33243741

[Ultrasound assessment of gastric insufflation in obese patients receiving transnasal humidified rapid-insufflation ventilatory exchange during general anesthesia induction].

Weiqing Jiang1, Li Shi1, Qian Zhao1, Wenwen Zhang1, Man Xu1, Wanling Wang1, Xiaoliang Wang1, Hongguang Bao1, Jing Leng2, Li Jiang3.   

Abstract

OBJECTIVE: To assess the effect of transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) on gastric insufflation during general anesthesia induction in obese patients.
METHODS: Ninety obese patients (BMI 30-39.9 kg/m2) undergoing laparoscopic cholecystectomy under general anesthesia were randomized into 3 groups (n=30) to receive facemask pre- oxygenation followed by face mask ventilation (FMV) after administration of anesthetics (Group M), oxygenation with THRIVE (Group T), or pre-oxygenation with facemask combined with THRIVE followed continuous oxygenation with both FMV and THRIVE after administration of anesthetics (Group M+T). The patients in the latter two groups received continuous oxygen via THRIVE during tracheal intubation. All the patients received real-time ultrasound monitoring of the gastric antrum, and positive gastric insufflation (GI+) was defined by the presence of comet-tail artifacts. The cross-sectional area of the gastic antrum (CSA-GA) was measured by ultrasound before and after pre-oxygenation and after intubation. The patients' SpO2, PaO2, and PaCO2 at admission (T1), 5 min after pre-oxygenation (T2), 5 min after medication (T3), and immediately after intubation (T4) were recorded, and the incidence of postoperative adverse events was assessed.
RESULTS: The incidence of gastric insufflation was significantly higher in Group M and Group M+T than in Group T (P < 0.05). The CSA-GA was significantly greater at T4 than at T1 in Group M and Group M+T and in their GI+s ubgroups. The GI+ subgroups in Group M and Group M+ T had significantly larger CSA-GA at T4 than the GI- subgroups (P < 0.05). CSA-GA did not vary significantly during anesthesia induction in Group T (P>0.05). The incidence of grade Ⅰ gastric distension was lower but grade Ⅱ gastric distention was higher in Group M and Group M+T than in Group T (P < 0.05). Group M showed significantly greater variations of PaO2 at T3 and T4 than Group T and Group M+T (P < 0.05).
CONCLUSIONS: Ultrasound monitoring of the comet tail sign and the changes of CSA-GA in the gastric antrum is feasible and reliable for detecting gastrointestinal airflow, and in obese patients, the application of THRIVE for induction of anesthesia can ensure the oxygenation level without further increasing gastric insufflation.

Entities:  

Keywords:  antrum area; gastric insufflation; gastric ultrasound; obesity; transnasal humidified rapidinsufflation ventilatory exchange

Mesh:

Year:  2020        PMID: 33243741      PMCID: PMC7704374          DOI: 10.12122/j.issn.1673-4254.2020.11.02

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  34 in total

1.  Effect of nasal continuous positive airway pressure on esophageal function.

Authors:  M R Fournier; P D Kerr; J P Shoenut; C S Yaffe
Journal:  J Otolaryngol       Date:  1999-06

2.  A two-handed jaw-thrust technique is superior to the one-handed "EC-clamp" technique for mask ventilation in the apneic unconscious person.

Authors:  Aaron M Joffe; Scott Hetzel; Elaine C Liew
Journal:  Anesthesiology       Date:  2010-10       Impact factor: 7.892

3.  Prevalence and factors predictive of full stomach in elective and emergency surgical patients: a prospective cohort study.

Authors:  L Bouvet; F-P Desgranges; C Aubergy; E Boselli; G Dupont; B Allaouchiche; D Chassard
Journal:  Br J Anaesth       Date:  2017-03-01       Impact factor: 9.166

4.  Anesthesiologists' learning curves for bedside qualitative ultrasound assessment of gastric content: a cohort study.

Authors:  Cristian Arzola; Jose C A Carvalho; Javier Cubillos; Xiang Y Ye; Anahi Perlas
Journal:  Can J Anaesth       Date:  2013-05-24       Impact factor: 5.063

5.  High-Flow Nasal Oxygen Improves Safe Apnea Time in Morbidly Obese Patients Undergoing General Anesthesia: A Randomized Controlled Trial.

Authors:  David T Wong; Amelie Dallaire; Kawal Preet Singh; Poorna Madhusudan; Timothy Jackson; Mandeep Singh; Jean Wong; Frances Chung
Journal:  Anesth Analg       Date:  2019-10       Impact factor: 5.108

Review 6.  Prevention of Oxygen Desaturation in Morbidly Obese Patients During Electroconvulsive Therapy: A Narrative Review.

Authors:  Yukihide Koyama; Koichi Tsuzaki; Takeshi Suzuki; Makoto Ozaki; Shigeru Saito
Journal:  J ECT       Date:  2020-09       Impact factor: 3.635

7.  Pressures delivered by nasal high flow oxygen during all phases of the respiratory cycle.

Authors:  Rachael L Parke; Shay P McGuinness
Journal:  Respir Care       Date:  2013-03-19       Impact factor: 2.258

Review 8.  A Systematic Review of the High-flow Nasal Cannula for Adult Patients.

Authors:  Yigal Helviz; Sharon Einav
Journal:  Crit Care       Date:  2018-03-20       Impact factor: 9.097

9.  Effect of facemask ventilation with different ventilating volumes on gastric insufflation during anesthesia induction in patients undergoing laparoscopic cholecystectomy.

Authors:  Wu Tianliang; Shao Gang; Yu Guocan; Fang Haixing
Journal:  Saudi Med J       Date:  2019-10       Impact factor: 1.484

10.  Comparison of preoxygenation with a high-flow nasal cannula and a simple mask before intubation during induction of general anesthesia in patients undergoing head and neck surgery: Study protocol clinical trial (SPIRIT Compliant).

Authors:  Jun-Young Jo; Wook-Jong Kim; Seungwoo Ku; Seong-Soo Choi
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

View more
  1 in total

1.  Efficacy of high-flow nasal oxygenation against peri- and post-procedural hypoxemia in patients with obesity: a meta-analysis of randomized controlled trials.

Authors:  Kuo-Chuan Hung; Ching-Chung Ko; Po-Chih Chang; Kuei-Fen Wang; I-Chia Teng; Chien-Hung Lin; Ping-Wen Huang; Cheuk-Kwan Sun
Journal:  Sci Rep       Date:  2022-04-19       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.